Navigation Links
Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C
Date:3/9/2009

erence call will be available within a few hours after the call ends. Investors may listen to the replay by dialing (888) 203-1112 or (719) 457-0820 confirmation code 4076361. Today's conference call also will be webcast and can be accessed at www.hgsi.com. Investors interested in listening to the live webcast should log on before the conference call begins to download any software required. Both the audio replay and the archive of the conference call webcast will remain available for several days.

About Human Genome Sciences

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax and cancer.

The Company's primary focus is rapid progress toward the commercialization of its two lead drugs, Albuferon(R) (albinterferon alfa-2b) for hepatitis C and LymphoStat-B(R) (belimumab) for lupus. Albuferon has now completed Phase 3 development, and the filing of global marketing applications is expected in fall 2009. Two Phase 3 clinical trials of LymphoStat-B are ongoing, with results expected in July and November 2009.

In January 2009, HGS began delivery of 20,000 doses of ABthrax(TM) (raxibacumab) to the U.S. Strategic National Stockpile for use in the event of an emergency for the treatment of inhalation anthrax. The Company also has several drugs in earlier stages of clinical development for the treatment of cancer, led by the TRAIL receptor antibody HGS-ETR1 and a small-molecule antagonist of IAP (inhibitor of apoptosis) proteins. In addition, HGS has substantial financial rights to certain products in the GSK clinical pipeline including darapladib, currently in Phase 3 development as a potential treatment for coronary heart disease, and Syncria(R) (albiglutide), curren
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Drug Development Program Started Based on CAP(R) Human Cell Line
2. Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
3. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
4. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
5. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
6. Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs
7. Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
8. Mardil Inc. Advances Its Novel Cardiac Device to First-In-Human Trials for Mitral Valve Regurgitation
9. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
10. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
11. Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... CHARLOTTE, N.C. , Aug. 21, 2014 /PRNewswire-iReach/ ... Home Medical Equipment, Inc. for the third straight ... annual Inc. 500|5000, an exclusive ranking of the ... most comprehensive look at the most important segment ... Yelp, Pandora, Timberland, Dell, Domino,s Pizza, LinkedIn, Zillow, ...
(Date:8/21/2014)... 21, 2014 BreedIT Corp., ... the exclusive worldwide license holder and distributor of ... and researchers, today is pleased to announce the ... Seach Ltd, a leading Israeli medical Cannabis breeder. ... develop new breeds of medical Cannabis to meet ...
(Date:8/21/2014)... Aug. 21, 2014  AliveCor, Inc. announced ... Administration (FDA) has granted the company clearance ... (AFib), the most common form of cardiac ... detects if patients are experiencing AFib through ... mobile phone based AliveCor® Heart Monitor, so ...
Breaking Medicine Technology:Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 4AliveCor Receives First FDA Clearance to Detect a Serious Heart Condition in an ECG on a Mobile Device 2
(Date:8/21/2014)... August 21, 2014 Pack Expo ... Packaging and Processing Technologies. They deliver the industry’s ... into a whole new world of advancement and ... interactive education, and the latest technology and innovations ... exhibitors. This year at Pack Expo International, 50,000 ...
(Date:8/21/2014)... 2014 Today, Zane Benefits, the #1 ... premium tax credits in 2015. , According to Zane ... of the Affordable Care Act (ACA), premium tax credits ... health insurance through the Health Insurance Marketplaces. , The ... the amount of the tax credits, updated for 2015. ...
(Date:8/21/2014)... support technology, the University of Michigan,s Transplant Center was ... pancreases available for transplant by about 20 percent. , ... and detail the impact of more than 10 ... improve the quality and viability of organs donated after ... by the number of donated organs available, so the ...
(Date:8/21/2014)... Md. (PRWEB) August 21, 2014 ... Houston with an Education Forum for PH patients ... , Who:    The Pulmonary Hypertension Association – ... to find ways to prevent and cure pulmonary ... that affects the functioning of the heart and ...
(Date:8/21/2014)... African American women born at a low or ... risk for developing type 2 diabetes. The findings, which ... part the higher occurrence of type 2 diabetes in ... low birth weight. , Researchers from Boston University,s Slone ... the Black Women,s Health Study over the course of ...
Breaking Medicine News(10 mins):Health News:Absolute I&D Provides Discounted Labor for Pack Expo Chicago 2Health News:Extracorporeal support can significantly increase number of organs for transplant 2Health News:Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease 2Health News:Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease 3Health News:Low birth weight linked to higher incidence of type 2 diabetes in African American women 2
... Shows Five Masimo Rad-57 Pulse CO-Oximeters(TM) Detected 83 Unsuspected ... UK Reported Annual CO PoisoningsIRVINE, Calif., Feb. 18 ... Pulse CO-Oximetry and Measure-Through Motion and Low-Perfusion pulse oximetry, ... UK House of Commons All Party Parliamentary Gas Safety ...
... Mass., Feb. 18 NeuroTherm(R) has introduced a revolutionary ... pain, S i mplicity lll. S i mplicity lll ... use in the treatment of pain associated with lumbar ... medical ailments in the world.(LOGO: http://www.newscom.com/cgi-bin/prnh/20090217/NE70925LOGO )"In my ...
... /PRNewswire-Asia-FirstCall/ -- China YCT International,Group Inc., (OTC Bulletin ... company engaged in the business of developing, manufacturing ... Shandong,Spring Pharmaceutical Co. Ltd, today announced its fiscal ... 31, 2008. , , Third ...
... The Quantum Group,Inc. (NYSE Amex: QGP ) ... on the President signing the American Recovery and Reinvestment ... allocates $19.2 billion to technology,and innovation for the healthcare ... it was publicly introduced. , ...
... CINCINNATI, Feb. 18 LCA-Vision Inc. (Nasdaq:, ... of Directors has elected Edgar,F. (Skip) Heizer, III ... Board of,Directors, bringing total Board membership to six, ... "Skip Heizer brings LCA-Vision extensive operational, legal, corporate,governance ...
... Bariatric Surgery Centers of Excellence to offer designees exclusive access ... surgery. , ... Portland, OR (PRWEB) ... specialized complication insurance coverage for elective surgery, today announced a ...
Cached Medicine News:Health News:United Kingdom House of Commons Safety Group Recommends Carbon Monoxide Screening by Pulse CO-Oximetry(TM) to Reduce Misdiagnosis and Prevent Deaths 2Health News:United Kingdom House of Commons Safety Group Recommends Carbon Monoxide Screening by Pulse CO-Oximetry(TM) to Reduce Misdiagnosis and Prevent Deaths 3Health News:United Kingdom House of Commons Safety Group Recommends Carbon Monoxide Screening by Pulse CO-Oximetry(TM) to Reduce Misdiagnosis and Prevent Deaths 4Health News:United Kingdom House of Commons Safety Group Recommends Carbon Monoxide Screening by Pulse CO-Oximetry(TM) to Reduce Misdiagnosis and Prevent Deaths 5Health News:United Kingdom House of Commons Safety Group Recommends Carbon Monoxide Screening by Pulse CO-Oximetry(TM) to Reduce Misdiagnosis and Prevent Deaths 6Health News:New Relief for Sufferers of Low Back Pain 2Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 2Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 3Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 4Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 5Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 6Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 7Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 8Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 9Health News:The Quantum Group Compliments Congress and President Obama on Signing of Stimulus Bill into Law 2Health News:The Quantum Group Compliments Congress and President Obama on Signing of Stimulus Bill into Law 3Health News:The Quantum Group Compliments Congress and President Obama on Signing of Stimulus Bill into Law 4Health News:LCA-Vision Announces Appointment of Edgar F. Heizer to Board of Directors 2Health News:BLIS™ Announces Alliance with Surgical Review Corporation to Offer Surgical Complication Insurance Coverage for Bariatric Surgery Center of Excellence Designees 2Health News:BLIS™ Announces Alliance with Surgical Review Corporation to Offer Surgical Complication Insurance Coverage for Bariatric Surgery Center of Excellence Designees 3
... Immune Complexes from patient serum or plasma, standards ... onto microtiter wells. After a washing step, ... binds to the Fc region of human IgG. ... is pipetted followed by a stopping step. ...
...
...
...
Medicine Products: